Short Interest in SanBio Company Limited (OTCMKTS:SNBIF) Expands By 53.7%

SanBio Company Limited (OTCMKTS:SNBIF) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 768,100 shares, a growth of 53.7% from the December 15th total of 499,800 shares. Based on an average trading volume of 500 shares, the short-interest ratio is currently 1,536.2 days.

SanBio Stock Performance

Shares of OTCMKTS:SNBIF remained flat at C$4.65 during midday trading on Friday. 129,950 shares of the company were exchanged, compared to its average volume of 2,364. SanBio has a fifty-two week low of C$4.65 and a fifty-two week high of C$5.92. The company’s 50 day simple moving average is C$4.66 and its two-hundred day simple moving average is C$4.13.

SanBio Company Profile

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.